Research and Markets (http://www.researchandmarkets.com/research/g5q44b/global_glaucoma)
has announced the addition of the "Global
Glaucoma Therapeutics Market Forecasts & Opportunities, 2018"
report to their offering.
Glaucoma is a disease of the eye in which fluid pressure within the eye
increases. If left untreated the patient may lose vision and even become
blind. The exact etiology of optic nerve damage due to glaucoma is not
fully known, but involves mechanical compression and/or decreased blood
flow in the optic nerve.
Based on whether the cause of the disease is unknown or known, glaucoma
is divided into two types, open angle and closed angle glaucoma. Five
main classes of medical treatment are currently used to lower
intraocular pressure: prostaglandins, beta blockers, alpha adrenergic
agonists, carbonic anhydrase inhibitors, and fixed dose combinations.
The Global Glaucoma Therapeutics market can be divided into five
segments: Prostaglandins, Beta Blockers, Alpha Adrenergic Agonists,
Carbonic Anhydrase Inhibitors, and Fixed Dose Combinations.
The report covers the Americas and the EMEA and APAC regions; it also
covers the Global Glaucoma Therapeutics market landscape and its growth
prospects in the coming years. The report also includes a discussion of
the key vendors operating in this market.
Other Prominent Vendors
Key Topics Covered:
For more information visit http://www.researchandmarkets.com/research/g5q44b/global_glaucoma
[ Back To NFVZone's Homepage ]